Rodino-Klapac Louise (CIK 0001836218)

Latest company ownership

Shares held
224,030
Last filed at
Nov 19, 2025
Confidence Score
44.5
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 17, 2025 Nov 19, 2025 Sarepta Therapeutics, Inc. President Sell 42.5 -4,582 -2.00% ✗ $84.4K
Mar 7, 2025 Mar 11, 2025 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 92.5 +4,813 6.03% ✗ $346.8K
Mar 6, 2025 Mar 10, 2025 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 40.0 -8,504 -10.27% ✗ $881.9K
Mar 4, 2025 Mar 6, 2025 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 42.5 -1,704 -2.54% ✗ $172.7K
Mar 3, 2025 Mar 4, 2025 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 42.5 -715 -1.06% ✗ $74.2K
Nov 18, 2024 Nov 20, 2024 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 40.0 -4,558 -6.31% ✗ $469K
Jun 21, 2024 Jun 25, 2024 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 40.0 -2,182 -2.94% ✗ $359.2K
Mar 7, 2024 Mar 11, 2024 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 42.5 -1,421 -2.04% ✗ $173.6K
Mar 4, 2024 Mar 6, 2024 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 42.5 -1,728 -2.43% ✗ $216.6K
Mar 1, 2024 Mar 5, 2024 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 90.0 +5,222 7.91% ✗ $98.2K
Nov 17, 2023 Nov 20, 2023 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 40.0 -4,508 -6.42% ✗ $374.1K
Mar 8, 2023 Mar 10, 2023 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 42.5 -912 -1.28% ✗ $139.7K
Mar 6, 2023 Mar 8, 2023 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 87.5 +3,366 4.97% ✗ $178.3K
Mar 1, 2023 Mar 3, 2023 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 45.0 -522 -0.76% ✗ $77K
Nov 17, 2022 Nov 21, 2022 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 40.0 -4,211 -5.83% ✗ $457K
Mar 4, 2022 Mar 8, 2022 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 95.0 +6,784 10.38% ✗ $96.3K
Mar 1, 2022 Mar 1, 2022 Sarepta Therapeutics, Inc. Head of R&D, CSO Sell 48.8 -572 -0.87% ✗ $42.9K
Nov 24, 2021 Nov 29, 2021 Sarepta Therapeutics, Inc. Head of R&D, CSO Buy 92.5 +3,780 6.11% ✗ $299.9K
Feb 28, 2021 Mar 10, 2021 Sarepta Therapeutics, Inc. Chief Scientific Officer Sell 91.3 +14,435 103.48% ✗ $49.1K